Current Report Filing (8-k)
January 09 2017 - 9:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 9, 2017
Aduro Biotech, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
|
|
|
|
|
001-37345
|
|
|
|
94-3348934
|
(Commission
File Number)
|
|
|
|
(IRS Employer
Identification No.)
|
740 Heinz Avenue
Berkeley, California
(Address of principal executive offices)
94710
(Zip Code)
Registrants telephone number, including area code: (510)
848-4400
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligations of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Attached hereto as Exhibit 99.1 is an investor presentation that Aduro
Biotech, Inc. plans to present during the 35
th
Annual J.P. Morgan Healthcare Conference on January 9, 2017.
Item 9.01
|
Financial Statements and Exhibits
|
|
|
|
Exhibit
|
|
Description
|
|
|
99.1
|
|
Aduro Biotech, Inc. Investor Presentation.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Dated: January 9, 2017
|
|
|
|
ADURO BIOTECH, INC.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Jennifer Lew
|
|
|
|
|
|
|
Jennifer Lew
|
|
|
|
|
|
|
Senior Vice President of Finance
|
3
EXHIBIT INDEX
|
|
|
Exhibit
|
|
Description
|
|
|
99.1
|
|
Aduro Biotech, Inc. Investor Presentation.
|
Aduro Biotech (NASDAQ:ADRO)
Historical Stock Chart
From Apr 2024 to May 2024
Aduro Biotech (NASDAQ:ADRO)
Historical Stock Chart
From May 2023 to May 2024